No Data
No Data
Lianhong Xinke: Report for the first quarter of 2025
Levima Advanced Materials Corporation (003022.SZ): In the first quarter, the net income was 71.4072 million yuan, a year-on-year increase of 38.83%.
On April 25th, Gelonghui reported that Levima Advanced Materials Corporation (003022.SZ) announced its first quarter report for 2025. In the first quarter of 2025, the company achieved revenue of 1,538.8922 million yuan, an increase of 3.48% year-on-year; the net income attributed to shareholders of the listed company was 71.4072 million yuan, an increase of 38.83% year-on-year; and the net income attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 70.2269 million yuan, an increase of 1,140.67% year-on-year. During the reporting period, the company experienced significant profit growth, mainly due to the following reasons: (1) continuous optimization of operation, primarily...
There Might Be More To Levima Advanced Materials' (SZSE:003022) Story Than Just Weak Earnings
Read This Before Judging Levima Advanced Materials Corporation's (SZSE:003022) ROE
The key materials in Siasun Robot&Automation's dexterous hands have a demand for tendons that is expected to accelerate growth.
① Currently, the robotics Industry Chain is receiving widespread attention. As one of the key materials in the robotics industry, tendon strings are replacing torsion springs, becoming a critical material; they are comparable to human tendons, pulling finger movements to complete various actions. ② HAITONG SEC points out that UHMWPE fibers are the main tendon string material for sophisticated robotic hands, and in the future, the demand is expected to accelerate due to the development of humanoid robots.
Levima Advanced Materials Corporation (003022.SZ): Currently, there are no electronic skin-related technologies or products in reserve.
On March 31, Gelonghui reported that Levima Advanced Materials Corporation (003022.SZ) stated on the investor interaction platform that the company currently has no technology or products related to electronic skin reserves.